Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time

Key Takeaway: BEDFORD, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 23, 2023, to discuss its financial and operating results for the fourth q
Price reaction · baseline $58.91 (2023-02-08 close) · hit after-hours · clean, no other LNTH news in the window
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is actively engaging with investors through a scheduled conference call.
  • The company shows commitment to improving patient outcomes.
  • The call will provide insights into financial performance and operating results.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+48%
120-day peak, hindsight
Typical move
2%
average across 7 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 23, 2023, to discuss its financial and operating results for the fourth quarter and full year of 2022.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Frequently Asked Questions

When is Lantheus Holdings' conference call?

The conference call will be on February 23, 2023, at 8:00 a.m. ET.

How can I access the conference call?

Participants can register online at Lantheus' investor relations website.

Is there a replay of the conference call available?

Yes, a replay will be available two hours after the call for 30 days.

What does Lantheus specialize in?

Lantheus focuses on diagnostics, radiotherapeutics, and AI solutions.

Where is Lantheus Holdings located?

Lantheus is based in Massachusetts and has offices in several locations.

Last updated: Feb 9, 2023